Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
More Videos
Is Drone Delivery Finally Ready for the Real World?
Matternet founder and CEO Andreas Raptopoulos on the state of drone delivery in the U.S. and what it will take to make aerial delivery a mainstream reality.
Powell Holds Firm: Why the Fed Is Refusing to Cut Rates Right Now
Truist's Head of US Economics Mike Skordeles breaks down the Fed's decision to hold rates steady and what it means for your money and the economy.
Simon Kim Is Building a Fine Dining Empire Out of Korean BBQ
Cote Steakhouse put Korean fine dining on the map. Now founder Simon Kim is eyeing his boldest move yet - a three-story NYC flagship
$84 Trillion Is Changing Hands: Here's How to Protect Your Legacy
Wells Fargo's Heather Hunt-Ruddy on the Great Wealth Transfer — what families must do now to protect, preserve, and pass on generational wealth.
Inside the Legal Battle Taking Aim at Anthropic
TechCrunch's Rebecca Bellan breaks down the lawsuit against Anthropic and what it could mean for the future of AI development and copyright law.
Meet the AI Agent Making Private Market Investing Accessible
Goodfin CEO Anna Joo Fee on Go, the company's new AI agent platform built to make private market investing smarter, faster, and more accessible.
